Conference Coverage (ICAAC)

So Far, So Good for HAART Patients Who Stop PCP Drugs

Published in TB and Outbreaks Week, November 24th, 1997

There have been no new or recurrent Pneumocystis carinii pneumonia (PCP) infections - so far - in a group of HIV infected patients who stopped their PCP prophylaxis after responding to highly active antiretroviral therapy (HAART).

The scientific debate continues over whether increased T-cell counts in HAART patients means that their immune systems have regained the ability to resist opportunistic infections.

Meanwhile, a group of patients at University Hospital, Utrecht, The Netherlands, are seeing for themselves.

"During the study period, no episodes of PCP have occurred," reported M.M.E. Schneider. "However, the median...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (1997-11-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry